(acquired by IBM)
|$2.18 to $73.20||3487%|
|$2.35 to $24.08||925%|
|Cellstar||$1.44 to $13.50||837%|
|Iomega||$3.25 to $13.90||328%|
|Nanophase||$3.75 to $16.75||347%|
|Immunomedics||$1.44 to $29.12||1922%|
|Total Renal Care||$3.12 to $26.95||741%|
|Voxware||$ .90 to $10.31||1046%|
|Corvas||$3.00 to $23.25||675%|
|Cytogen||$2.12 to $17.50||725%|
|Verilink||$3.00 to $14.62||387%|
|GeneLabs||$2.31 to $10.72||364%|
WE CLOSED INTELLICHECK AT $4.03 FOR A 52% GAIN!
WE CLOSED ADMA OTONOMY AT $3.15 FOR AN 55% GAIN!
The late-May Newsletter is now live and featured are a diagnostic comapny whose products are sold in over 100 countries and trades at around $2.35; while the other is a biotech that is a BUY OF EIGHT ANALYSTS, trades at about $2.80, and has collaborations with nearly half-dozen pharmas.
In the early to mid-June Newsletter we will featured TWO CHANNELED STOCKS. One is a medical device maker trading at around 60 cents while the other is a biotech trading at $1.90.
"I cannot thank you enough for your excellent newsletter... I do believe I have found a new hobby (and a well paying one, at that), thanks to you!"
— B.K. (Contractor in Saudi Arabia)